Oral ethinylestradiol–levonorgestrel therapy counteracts fructose-induced renal metabolic impairment in female rats

Oral ethinylestradiol–levonorgestrel therapy counteracts fructose-induced renal metabolic impairment in female rats

Background: The excessive intake of fructose (FRD) induces insulin resistance (IR)-associated renal impairment. Similarly, the use of estrogen-progestin oral contraceptive therapy (EEL) has been associated with cardiometabolic syndrome, and its non-contraceptive benefits particularly in metabolic pa...

Full description

Bibliographic Details
Main Authors: Kehinde Samuel Olaniyi, Isaiah Woru Sabinari, Lawrence Aderemi Olatunji
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Endocrine and Metabolic Science
Subjects:
Cardiometabolic syndrome
Ethinylestradiol–levonorgestrel
Fructose
Nitric oxide
Renal function
Online Access:http://www.sciencedirect.com/science/article/pii/S2666396121000224

Internet

http://www.sciencedirect.com/science/article/pii/S2666396121000224

Similar Items